Oncology Institute, Inc. (TOI) EBT Margin (2021 - 2026)
Oncology Institute's (TOI) quarterly EBT Margin came in at 1.69% in Q1 2026, up 1707.0% YoY from 0.09% in Q1 2025, and up 68.04% on a QoQ basis from 5.29% in Q4 2025.
Oncology Institute, Inc. (TOI) EBT Margin (2021 - 2026) Analysis & Trends
Oncology Institute (TOI) has 6 years of EBT Margin data on file, last reported at 1.69% in Q1 2026.
- Quarterly EBT Margin rose 1707.0% year-over-year to 1.69% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.0% (up 797.0% YoY) and the FY2025 annual result came in at 12.08%, up 435.0% from the prior year.
- EBT Margin advanced to 1.69% in Q1 2026, from 5.29% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 35.29% in Q1 2022 to a low of 39.31% in Q1 2023.
- A 5-year average of 12.67% and a median of 15.7% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin surged 3689 bps — and 2023, when it tumbled 7460 bps.
- Tracing TOI's EBT Margin over 5 years: stood at 15.92% in 2022, then slumped by 40 bps to 22.23% in 2023, then surged by 41 bps to 13.15% in 2024, then surged by 60 bps to 5.29% in 2025, then soared by 68 bps to 1.69% in 2026.
- The last three EBT Margin figures came in at 1.69% (Q1 2026), 5.29% (Q4 2025), and 12.09% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.07% |
| Mar 31, 2026 | -1.69% |
| Dec 31, 2025 | -5.29% |
| Sep 30, 2025 | -12.09% |
| Jun 30, 2025 | -14.31% |
| Mar 31, 2025 | -18.76% |
| Dec 31, 2024 | -13.15% |
| Sep 30, 2024 | -16.13% |
| Jun 30, 2024 | -15.70% |
| Mar 31, 2024 | -21.01% |
| Dec 31, 2023 | -22.23% |
| Sep 30, 2023 | -21.07% |
| Jun 30, 2023 | -20.94% |
| Mar 31, 2023 | -39.31% |
| Dec 31, 2022 | -15.92% |
| Sep 30, 2022 | -4.15% |
| Jun 30, 2022 | -9.00% |
| Mar 31, 2022 | 35.29% |
| Dec 31, 2021 | -24.14% |
| Sep 30, 2021 | -4.17% |